- Home
- VKTX vs CALX Comparison
VKTX vs CALX Comparison
Compare VKTX & CALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- CALX
- Stock Information
- Founded
- VKTX 2012
- CALX 1999
- Country
- VKTX United States
- CALX United States
- Employees
- VKTX N/A
- CALX N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- CALX Telecommunications Equipment
- Sector
- VKTX Health Care
- CALX Consumer Discretionary
- Exchange
- VKTX Nasdaq
- CALX Nasdaq
- Market Cap
- VKTX 3.8B
- CALX 4.2B
- IPO Year
- VKTX 2015
- CALX 2010
- Fundamental
- Price
- VKTX $34.40
- CALX $53.96
- Analyst Decision
- VKTX Strong Buy
- CALX Strong Buy
- Analyst Count
- VKTX 14
- CALX 5
- Target Price
- VKTX $87.07
- CALX $77.75
- AVG Volume (30 Days)
- VKTX 4.3M
- CALX 853.8K
- Earning Date
- VKTX 10-22-2025
- CALX 10-29-2025
- Dividend Yield
- VKTX N/A
- CALX N/A
- EPS Growth
- VKTX N/A
- CALX N/A
- EPS
- VKTX N/A
- CALX N/A
- Revenue
- VKTX N/A
- CALX $933,685,000.00
- Revenue This Year
- VKTX N/A
- CALX $19.95
- Revenue Next Year
- VKTX N/A
- CALX $12.89
- P/E Ratio
- VKTX N/A
- CALX N/A
- Revenue Growth
- VKTX N/A
- CALX 4.89
- 52 Week Low
- VKTX $18.92
- CALX $28.61
- 52 Week High
- VKTX $56.25
- CALX $71.22
- Technical
- Relative Strength Index (RSI)
- VKTX 44.88
- CALX 30.88
- Support Level
- VKTX $34.67
- CALX $54.51
- Resistance Level
- VKTX $43.15
- CALX $56.85
- Average True Range (ATR)
- VKTX 2.70
- CALX 2.36
- MACD
- VKTX -0.69
- CALX -1.30
- Stochastic Oscillator
- VKTX 13.85
- CALX 12.05
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About CALX Calix Inc
Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.